Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$19.50 -0.66 (-3.27%)
At close: Sep 22, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Free Cash Flow (2017 - 2026)

Amneal Pharmaceuticals (AMRX) posted Free Cash Flow of -$51.9 million for Q2 2026, down 48.75% on a QoQ basis from -$34.9 million in Q1 2026, and down 185.16% year-over-year from $61.0 million in Q2 2025.

Analysis

Amneal Pharmaceuticals (AMRX) Free Cash Flow (2017 - 2026) Analysis & Trends

Amneal Pharmaceuticals has reported Free Cash Flow for 10 years, with the latest figure at -$51.9 million in Q2 2026.

  • On a quarterly basis, Free Cash Flow fell 185.16% year-over-year to -$51.9 million in Q2 2026; TTM through Jun 2026 was $127.8 million, a 54.83% decrease from a year earlier, with the FY2025 full-year figure at $269.9 million, up 11.0% from the prior year.
  • Free Cash Flow was -$51.9 million for Q2 2026 at Amneal Pharmaceuticals, down from -$34.9 million in the prior quarter.
  • The five-year high for Free Cash Flow was $130.0 million in Q1 2023, with the low at -$130.6 million in Q2 2022.
  • Average Free Cash Flow over 5 years is $41.5 million, with a median of $65.4 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2026: Free Cash Flow jumped 462.39% in 2023, then plunged 506.85% in 2026.
  • Over 5 years, Free Cash Flow stood at -$34.8 million in 2022, then surged by 462.39% to $126.0 million in 2023, then retreated by 18.29% to $102.9 million in 2024, then gained by 5.46% to $108.5 million in 2025, then sank by 147.85% to -$51.9 million in 2026.
  • The last three Free Cash Flow figures came in at -$51.9 million (Q2 2026), -$34.9 million (Q1 2026), and $108.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 307.00 Mn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 329.00 Mn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 26.40 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn -51.94 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 593.00 Mn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 53.62 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 8.08 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 42.73 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn -
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 -584,999.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.94 Mn
Mar 31, 2026 -34.92 Mn
Dec 31, 2025 108.54 Mn
Sep 30, 2025 106.15 Mn
Jun 30, 2025 60.99 Mn
Mar 31, 2025 -5.75 Mn
Dec 31, 2024 102.92 Mn
Sep 30, 2024 124.83 Mn
Jun 30, 2024 29.03 Mn
Mar 31, 2024 -13.61 Mn
Dec 31, 2023 125.96 Mn
Sep 30, 2023 69.73 Mn
Jun 30, 2023 -23.35 Mn
Mar 31, 2023 130.02 Mn
Dec 31, 2022 -34.76 Mn
Sep 30, 2022 74.47 Mn
Jun 30, 2022 -130.57 Mn
Mar 31, 2022 109.55 Mn
Dec 31, 2021 45.76 Mn
Sep 30, 2021 71.72 Mn
API Access

Amneal Pharmaceuticals Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=AMRX&period=max&api_key=YOUR_API_KEY